{"url":"https://lda.senate.gov/api/v1/filings/119f5f4e-25b0-4666-a1ff-72c54d856bfe/","filing_uuid":"119f5f4e-25b0-4666-a1ff-72c54d856bfe","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2016,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/119f5f4e-25b0-4666-a1ff-72c54d856bfe/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Margaret Tighe","dt_posted":"2016-07-15T09:57:40.003000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1501 M Street, NW","registrant_address_2":"Seventh Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":32008,"url":"https://lda.senate.gov/api/v1/registrants/32008/","house_registrant_id":32107,"name":"POWERS PYLES SUTTER & VERVILLE, P.C.","description":"Law Firm.","address_1":"1250 Connecticut Ave NW","address_2":"Eighth Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PETER THOMAS","contact_telephone":"+1 202-466-6550","dt_updated":"2026-07-29T18:34:29.769972-04:00"},"client":{"id":139555,"url":"https://lda.senate.gov/api/v1/clients/139555/","client_id":1004303,"name":"CLEVERCAP","general_description":"Health technology service company with a device-enabled medication adherence platform.","client_government_entity":false,"client_self_select":null,"state":"FL","state_display":"Florida","country":"US","country_display":"United States of America","ppb_state":"FL","ppb_state_display":"Florida","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-12-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Legislation including technologies focused on patient adherence to drug regimes and minimizing likelihood of diversion.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58433,"prefix":"ms","prefix_display":"MS.","first_name":"MARGARET","nickname":null,"middle_name":"E.","last_name":"TIGHE","suffix":null,"suffix_display":null},"covered_position":"Counsel","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}